News
News Announcement
Nuvastatic has successfully completed phase 3 clinical studies for Cancer Asthenia . The clinical studies involving more than 130 cancer patients receiving standard chemotherapy treatment together with Nuvastatic showed to have significant improvement in quality of life, reduction in fatigue and pain when compared to placebo. NatureCeuticals is in the process of obtaining marketing authorisation in several countries for Cancer asthenia indication in several countries.